⚙
AI-generated deep summary
by claude@2026-07, 2026-07-03
· read from full text
ⓘ
This paper evaluates whether low-intensity focused ultrasound can fragment amyloid fibrin(ogen) microclots formed in a laboratory model, and tests how cavitation and microbubble assistance affect lysis compared with rtPA. Using freeze-thaw–generated microclots exposed to ultrasound at 150 kHz, 300 kHz, 500 kHz, and 1 MHz under conditions of ultrasound alone, microbubbles plus ultrasound, rtPA plus ultrasound, or both microbubbles and rtPA plus ultrasound, the authors found that 150 kHz ultrasound produced significant clot lysis with up to a three-fold reduction in clot size and large-clot number, and that microbubbles enhanced lysis at several frequencies. The combination of ultrasound with microbubbles and rtPA further improved clot fragmentation. The study is limited to in vitro microclot models rather than patient-derived samples or in vivo outcomes, and it is conducted with device-company involvement (Openwater). This paper is not about endometriosis or adenomyosis; it is included in the corpus due to its stated relevance to thrombo-inflammatory conditions and Long COVID, but it does not explicitly discuss endometriosis or adenomyosis.
Abstract
Amyloid fibrin(ogen) microclots are misfolded protein aggregates with β-sheet structures that have been associated with Long COVID and numerous thrombo-inflammatory diseases. These microclots persist in circulation and obstruct microvasculature, impair oxygen transport and promote chronic inflammation. Conventional thrombolytic therapies such as recombinant tissue plasminogen activator (rtPA) show limited efficacy against these aggregates due to their structure and composition. In this study, we assess the impact of low intensity focused ultrasound (LIFU) stimulation on amyloid microclot fragmentation, the role of cavitation in this process and investigate whether microbubble-assisted ultrasound can enhance their lysis. Amyloid microclot models were generated using freeze-thaw cycles followed by incubation. Microclots were exposed to ultrasound waves at 150 kHz, 300 kHz, 500 kHz, and 1 MHz under four conditions: ultrasound alone (US), ultrasound with microbubbles (MB + US), ultrasound with rtPA (rtPA + US), and ultrasound with both microbubbles and rtPA (MB + rtPA + US). Low-frequency ultrasound at 150 kHz resulted in a significant clot lysis with up to three-fold reduction in both clot size and the number of large clots. The addition of microbubbles enhanced clot lysis at 150 kHz, 300 kHz, and 500 kHz. These findings suggest that ultrasound, particularly at 150 kHz, is a promising method for amyloid microclot lysis. The combination of ultrasound with microbubbles and rtPA further improved clot fragmentation, rendering it a potential therapeutic tool for conditions like Long COVID.
Full text
1,697 characters
· extracted from
oa-doi-fallback
· click to expand
Abstract
Amyloid fibrin(ogen) microclots are misfolded protein aggregates with β-sheet structures that have been associated with Long COVID and numerous thrombo-inflammatory diseases. These microclots persist in circulation and obstruct microvasculature, impair oxygen transport and promote chronic inflammation. Conventional thrombolytic therapies such as recombinant tissue plasminogen activator (rtPA) show limited efficacy against these aggregates due to their structure and composition. In this study, we assess the impact of low intensity focused ultrasound (LIFU) stimulation on amyloid microclot fragmentation, the role of cavitation in this process and investigate whether microbubble-assisted ultrasound can enhance their lysis. Amyloid microclot models were generated using freeze-thaw cycles followed by incubation. Microclots were exposed to ultrasound waves at 150 kHz, 300 kHz, 500 kHz, and 1 MHz under four conditions: ultrasound alone (US), ultrasound with microbubbles (MB + US), ultrasound with rtPA (rtPA + US), and ultrasound with both microbubbles and rtPA (MB + rtPA + US). Low-frequency ultrasound at 150 kHz resulted in a significant clot lysis with up to three-fold reduction in both clot size and the number of large clots. The addition of microbubbles enhanced clot lysis at 150 kHz, 300 kHz, and 500 kHz. These findings suggest that ultrasound, particularly at 150 kHz, is a promising method for amyloid microclot lysis. The combination of ultrasound with microbubbles and rtPA further improved clot fragmentation, rendering it a potential therapeutic tool for conditions like Long COVID.
Competing Interest Statement
Openwater is an Opensource medical device company.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.